Bryan Gillis
Plus aucun poste en cours
Profil
Bryan Gillis worked as the Vice President-Manufacturing & Supply at Rubius Therapeutics, Inc. from 2018 to 2022.
He then served as the Chief Technology Officer at Finch Therapeutics Group, Inc. in 2022 to 2023.
Mr. Gillis holds an MBA from Boston University and an undergraduate degree from Eastern Nazarene College.
Anciens postes connus de Bryan Gillis
| Sociétés | Poste | Fin |
|---|---|---|
| FINCH THERAPEUTICS GROUP, INC. | Directeur Technique/Scientifique/R&D | 01/03/2023 |
| RUBIUS THERAPEUTICS | Corporate Officer/Principal | 01/02/2022 |
Formation de Bryan Gillis
| Eastern Nazarene College | Undergraduate Degree |
| Boston University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| FINCH THERAPEUTICS GROUP, INC. | Health Services |
| Entreprise privées | 1 |
|---|---|
Rubius Therapeutics, Inc.
 Rubius Therapeutics, Inc. BiotechnologyHealth Technology Rubius Therapeutics, Inc. engages in the development of red-cell therapeutic medicines. It provides medicine for cancer, autoimmune diseases, hemophilia, infectious and metabolic diseases. The company was founded on April 26, 2013 and is headquartered in Foxboro, MA. | Health Technology |
